Can a drug developed for sickle cell anemia mitigate lung damage in patients with COVID-19?

(University of California - Davis Health) Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19. The senicapoc study will assess whether the drug can prevent SARS and lung damage and reduce days spent on a ventilator.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news